Response to neoadjuvant therapy:PrThr:Pt:Colorectal cancer specimen:Ord: - CISMeF
Response to neoadjuvant therapy:PrThr:Pt:Colorectal cancer specimen:Ord:LOINC code
Preferred Label : Response to neoadjuvant therapy:PrThr:Pt:Colorectal cancer specimen:Ord:;
LOINC status : ACTIVE;
LOINC display name : Response to neoadjuvant therapy Ql (Colorectal cancer specimen);
LOINC long common name : Tumor response to neoadjuvant therapy;
LOINC short name : Tumor resp to neoadjvt therapy;
LOINC description : The response of the tumor to neoadjuvant treatment, such as chemotherapy and radiotherapy.
Chemotherapy and/or radiotherapy before resection is associated with significant downstaging
and improved prognosis. These specimens require close gross examination and additional
blocking to demonstrate tumor. The degree of tumor regression has been shown to correlate
with prognosis. This term was created for, but not limited in use to, the Colorectal
Cancer Structured Reporting Protocol (2nd Edition, 2012) developed by the Royal College
of Pathologists of Australasia (RCPA).;